STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. ETNB
  4. [EFFECT] 89bio, Inc. SEC Filing

[EFFECT] 89bio, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 19, 2025
Accession Number: 0001193125-25-258723
Submission Type: POS AM
CIK: 0001785173
Company Name: 89bio, Inc.
File Number: 333-269471

Source: View Original Filing on SEC EDGAR

Stock ETNB logo
89Bio, Inc.

NASDAQ:ETNB

ETNB Rankings

#2007 Ranked by Market Cap
N/A Ranked by Dividends

ETNB Latest News

Sep 18, 2025
89bio, Inc. Announces Agreement to be Acquired by Roche
Sep 5, 2025
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 28, 2025
89bio to Participate in Upcoming Investor Conferences
Aug 7, 2025
89bio Reports Second Quarter 2025 Financial Results and Corporate Updates
Aug 4, 2025
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ETNB Latest SEC Filings

Nov 3, 2025
[Form 4] 89bio, Inc. Insider Trading Activity
Oct 30, 2025
[Form 4] 89bio, Inc. Insider Trading Activity
Oct 30, 2025
[Form 4] 89bio, Inc. Insider Trading Activity
Oct 30, 2025
[Form 4] 89bio, Inc. Insider Trading Activity
Oct 30, 2025
[Form 4] 89bio, Inc. Insider Trading Activity

ETNB Stock Data

2.20B
147.57M
0.54%
111.85%
11.05%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN FRANCISCO